Actively Recruiting
Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
Led by Beijing Anzhen Hospital · Updated on 2025-06-12
2000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the clinical outcomes of different treatment strategies for neuro-co-cardiological diseases and cerebrovascular diseases following cardiac surgery. This observational study also aims to identify factors that influence negative outcomes from these treatments. The trial is sponsored by Beijing Anzhen Hospital and focuses on patients aged 18 years and older with these specific conditions. Participants are grouped based on the treatment approach they receive, including simultaneous interventional, surgical, or hybrid surgical treatments; staged interventional, surgical, or hybrid treatments; conservative treatment alongside surgery or intervention; and treatments specifically for cerebrovascular disease following cardiac surgery, either surgical/interventional or conservative. These treatment strategies are observed without intervention from the study team. During the study, participants will be monitored using the Modified Rankin Scale Score at various time points including around 7 days, 90 days, and one year. The study also tracks perioperative complications and rates of cardiovascular and cerebrovascular events up to one year. Participants will undergo evaluations to assess both short-term and long-term complications related to their treatment. The total duration of involvement varies based on follow-up assessments up to 365 days.
CONDITIONS
Brief Title
Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases
You will not qualify if you...
- Expected survival less than 1 year
- Presence of other serious diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of treatment depends on assigned intervention strategy
Participants receive interventional or surgical treatment according to their assigned strategy, which may be simultaneous, staged, or conservative treatment for neuro-co-cardiological or post-cardiac surgery cerebrovascular diseases.
1 to 2 visits depending on treatment strategy
Duration - Up to 12 months
Participants are monitored for complications and outcomes after treatment, including assessments up to 1 year post-treatment.
Visits at approximately 7 days, 30 days, 90 days, and 365 days post-treatment
Trial Site Locations
Total: 1 location
1
Beijing Anzhen Hospital
Beijing, China
Actively Recruiting
Research Team
X
Xiaochuan Huo, M.D.
X
Xin Tong, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here